🔗 Permalink

Inventor profile of:

William D. Shrader

City:

Belmont, California

Country:

United States

Published Applications:

Last publication date:

2024-06-13

Top Assignees for applications by William D. Shrader

The entities that hold a legal rights for patent applications filed by inventor Shrader William D.:

EDISON PHARMACEUTICALS, INC. 9 Mountain View, CA United States
BioElectron Technology Corporation 4 Mountain View, CA United States
PTC THERAPEUTICS, INC. 2 South Plainfield, NJ United States
Edison Pharmaceuticals, Inc. 1 San Jose, CA United States
Reiley Pharmaceuticals, Inc. 1 San Jose, CA United States

Recent patent applications by Shrader William D.

William D. Shrader from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-13

US20240190790A1

Chemistry; metallurgy

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

#2 | 2022-01-20

US20220017432A1

Chemistry; metallurgy

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

#3 | 2021-06-17

US20210179542A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#4 | 2020-04-23

US20200121618A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS

#5 | 2019-09-05

US20190270699A1

Chemistry; metallurgy

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#6 | 2019-06-06

US20190169084A1

Chemistry; metallurgy

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

#7 | 2018-06-14

US20180162784A1

Chemistry; metallurgy

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

#8 | 2018-05-03

US20180116978A1

Human necessities

FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES

#9 | 2017-11-02

US20170313649A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#10 | 2017-07-27

US20170209393A1

Human necessities

BENZOQUINONE DERIVATIVES FOR TREATING OXIDATIVE STRESS DISORDERS

#11 | 2016-04-28

US20160115141A1

Chemistry; metallurgy

CARBOXYLIC ACID DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

#12 | 2016-03-17

US20160075638A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#13 | 2016-02-11

US20160039776A1

Chemistry; metallurgy

Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders

#14 | 2016-02-11

US20160039775A1

Chemistry; metallurgy

Resorufin derivatives for treatment of oxidative stress disorders

#15 | 2015-12-31

US20150374858A1

Human necessities

Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging

#16 | 2015-08-06

US20150218079A1

Chemistry; metallurgy

Benzoquinone derivatives for treating oxidative stress disorders

#17 | 2015-08-06

US20150216820A1

Human necessities

QUINONE DERIVATIVES FOR USE IN THE MODULATION OF REDOX STATUS OF INDIVIDUALS

#18 | 2014-11-06

US20140329860A1

Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#19 | 2014-09-18

US20140275054A1

Chemistry; metallurgy

Resorufin derivatives for treatment of oxidative stress disorders

#20 | 2014-09-18

US20140275045A1

Chemistry; metallurgy

PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

#21 | 2014-01-30

US20140031433A1

Human necessities

FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES

#22 | 2013-10-31

US20130289034A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#23 | 2013-05-09

US20130116336A1

Human necessities

TREATMENT OF ATAXIA TELANGIECTASIA

#24 | 2012-11-22

US20120295985A1

Human necessities

METHODS FOR IMPROVING BLOOD GLUCOSE CONTROL

#25 | 2012-05-31

US20120136048A1

Human necessities

TOPICAL, PERIOCULAR, OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES

#26 | 2012-05-17

US20120122934A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#27 | 2011-05-26

US20110124679A1

Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#28 | 2010-10-28

US20100273892A1

Human necessities

FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES

#29 | 2010-03-04

US20100056429A1

Human necessities

TREATMENT OF RESPIRATORY CHAIN DISORDERS USING COMPOUNDS HAVING ERYTHROPOIETIN OR THROMBOPOIETIN ACTIVITY

#30 | 2009-11-26

US20090291092A1

Human necessities

TREATMENT OF MITOCHONDRIAL DISEASES WITH AN ERYTHROPOIETIN MIMETIC

#31 | 2009-05-07

US20090118257A1

Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

InventorID:

236535 ⎘